Vivos Therapeutics Inc (VVOS) earnings · rev $17.4M
These earnings events as JSON? API free 100/dayVivos Therapeutics Inc (VVOS) is a medical devices company listed on NASDAQ.
This VVOS earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported VVOS revenue for 2025-12-31 was $17.4M. Net income was -$21.2M. Revenue was up 16.0% from 2024-12-31 to 2025-12-31. VVOS currently screens at market cap $7.1M.
When the next VVOS 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 16.0% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full VVOS research stays on the stock page; the tape stays on the quote page.
VVOS earnings FAQ
What are VVOS's latest revenue and net income?
Latest cached Vivos Therapeutics Inc (VVOS) revenue for Dec 31, 2025 was $17.4M. Net income was -$21.2M. Statements: https://lician.com/financials/vvos
What is VVOS's latest diluted EPS?
Latest cached Vivos Therapeutics Inc (VVOS) diluted EPS for Dec 31, 2025 was -$2.07.
What period does the latest VVOS earnings print cover?
The latest cached Vivos Therapeutics Inc (VVOS) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did VVOS revenue change from the prior cached period?
Cached Vivos Therapeutics Inc (VVOS) revenue was up 16.0% from $15.0M (Dec 31, 2024) to $17.4M (Dec 31, 2025). Statements: https://lician.com/financials/vvos
Where are VVOS earnings listed?
Cached earnings facts for Vivos Therapeutics Inc (VVOS) are listed at https://lician.com/earnings/vvos. Statements: https://lician.com/financials/vvos
Not investment advice.